Sigilon Therapeutics Inc (SGTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 42,316 | 107,393 | 202,304 | 76,069 | N/A |
| Marketable Securities | 27,560 | 16,213 | N/A | N/A | N/A |
| Receivables | 3,458 | 59 | 177 | 136 | N/A |
| TOTAL | $74,411 | $126,394 | $204,210 | $76,937 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 2,854 | 3,994 | 2,991 | 2,949 | N/A |
| Other Non-Current Assets | 10,013 | 13,981 | 17,849 | 10,492 | 0 |
| TOTAL | $12,867 | $17,975 | $20,840 | $13,441 | $N/A |
| Total Assets | $87,278 | $144,369 | $225,050 | $90,378 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 6,667 | 1,667 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 936 | 2,344 | 1,988 | 2,005 | 0 |
| Accrued Expenses | 6,021 | 8,998 | 7,892 | 5,852 | N/A |
| TOTAL | $30,994 | $34,888 | $47,018 | $40,375 | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | 12,021 | 18,411 | 19,807 | 14,868 | N/A |
| Deferred Revenues | 12,885 | 17,034 | 31,777 | 29,140 | N/A |
| Other Non-Current Liabilities | 5,121 | 8,577 | 12,069 | 97,347 | 0 |
| TOTAL | $17,142 | $32,321 | $31,876 | $127,765 | $N/A |
| Total Liabilities | $48,136 | $67,209 | $78,894 | $168,140 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,497 | 2,489 | N/A | N/A | N/A |
| Common Shares | 32 | 32 | 31 | 5 | N/A |
| Retained earnings | -256,800 | -213,239 | -135,928 | -81,320 | N/A |
| Other shareholders' equity | -429 | -10 | 0 | 0 | 0 |
| TOTAL | $39,142 | $77,160 | $146,156 | $-77,762 | $N/A |
| Total Liabilities And Equity | $87,278 | $144,369 | $225,050 | $90,378 | $0 |